Pfizer’s chief executive officer Ian Read is to step down after eight years at the helm of the US pharma giant and take on the role of executive chairman. On 1 January 2019, he will be succeeded by chief operating officer Albert Bourla, who won the “unanimous support” of Pfizer’s board.
Bourla has served as chief operating officer since 1 January 2018, having previously led Pfizer’s Innovative Health business, which currently...




